Keywords: fda, clears, new, strengths, novartis, stalevo, swiss

FDA clears two new strengths of Novartis' Stalevo

Article | 03 November 2008

Print This

Swiss drug major Novartis says the US Food and Drug Administration has approved two new dose strengths of Parkinson's disease ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in